A-Alpha Bio

About A-Alpha Bio

A-Alpha Bio is a company that harnesses synthetic biology and machine learning to engineer high-impact medicines. They focus on measuring millions of protein-protein interactions simultaneously to accelerate innovation and improve human health.

Products & Services

AlphaSeq:A leading platform for quantitative and multiplexed characterization of protein-protein interactions, generating the largest repository of high-quality protein interaction data.

AlphaBind:A tool that uses accumulated data to train machine learning models for predicting protein binding from sequence, with computational designs validated experimentally.

Specialties

Synthetic Biology Machine Learning Protein-Protein Interactions Drug Discovery Antibody Development Protein Interface Engineering

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 14500000 MR: - FA: $14.5M FAN: 14500000	D: 2024-05-21 FD: 2024-05-21	1 investors
2	RT: Series A2 T: - FT: Series A2	A: 22400000 MR: - FA: 22.4M FAN: 22400000	D: 2023-07-25 FD: 2023-07-25	3 investors

Grant Latest

2024-05-21

$14.5M

1 investor (Pro only)

Series A2 2023-07-25

$22.4M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

David Younger

Chief Executive Officer & Co-Founder

R

Randolph Lopez

Chief Technology Officer & Co-Founder

T

Troy Lionberger, PhD

Chief Business Officer

R

Ryan Emerson

Senior Vice President, Data Science & Platform Solutions

L

Lisa Schubert

Vice President, Technical Operations & Engineering

D

David Baker

Scientific Advisor

View 51 more team members with Pro

Unlock Full Team Directory

Recent News

A-Alpha Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised